REPOCH compared with RCHOP for the treatment of diffuse large B-cell lymphoma of activated B-cell type.

Phillip Martinez-Knouse,Edward Nabrinsky,Anjana Chandran,Timothy M. Lestingi,Jacob D. Bitran

REPOCH compared with RCHOP for the treatment of diffuse large B-cell lymphoma of activated B-cell type.

2020

Phillip Martinez-Knouse
Edward Nabrinsky
Anjana Chandran
Timothy M. Lestingi
Jacob D. Bitran

e20081Background: Patients with diffuse large B-cell lymphoma of activated B-cell type (DLBCL-ABC) have a worse prognosis than patients with DLBCL of germinal center origin. Recently, a phase III r...

Keywords:

Diffuse large B-cell lymphoma
B cell
Pathology
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations